MTOR and prostate carcinoma: On the other hand, MLST8 stabilizes the raptor-MTOR interaction and promotes mTORC1 activity [12], and upregulation of MLST8 enhances mTORC1/2 activities in colon carcinoma and prostate cancer [13].